Patient survival with renal replacement therapy in heart transplantation patients

ASAIO Journal

Volumn 44, Issue 5, 1998, Pages

  Bernardini, Judith ^a   Piraino, Beth ^a,b   Kormos, Robert L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b A915 Scaife Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR SYSTEM; DIALYSIS; GRAFT VS. HOST REACTIONS; TOXICITY; TRANSPLANTATION (SURGICAL); UROLOGY;

CARDIAC TRANSPLANTATION; HEMODIALYSIS; IMMUNOSUPPRESSIVE THERAPY; NEPHROTOXICITY; PERITONEAL DIALYSIS; RENAL REPLACEMENT THERAPY;

DRUG THERAPY;

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART TRANSPLANTATION; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; MALE; NEPHROTOXICITY; PERITONEAL DIALYSIS; SURVIVAL RATE;

EID: 0032170060     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199809000-00046     Document Type: Article

References (5)

1. Sehgal V, Radhakrishnan J, Appel GB, Valeri A, Cohen D: Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients Am J Kidney Dis 26: 193-201, 1995.
2. Goldstein DJ, Zuech N, Sehgal V, Weinberg AD, Drusin R, Cohen D: Cyclosporine-associated end-stage nephropathy after cardiac transplantation. Transplantation 63: 664-668, 1997.
3. Kuo CK, Luikart H, Busse-Henry S, Hunt SA, Valantine HA, Stinson EB, Oyer PE, Scandling JD, Alfrey EJ, Dafoe DC: Clin Transplant 9: 92-107, 1995.
4. Greenberg A, Thompson ME, Griffith BJ, Hardesty RL, Kormos RL, El-Shahawy MA, Janosky JE, Puschett JB: Cyclosporine nephrotoxicity in cardiac allograft patients: a seven-year follow-up. Transplantation 50: 589-593, 1990.
5. Asante-Korang A, Boyle GJ, Webber SA, Miller SA, Fricker FJ: Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects. J Heart Lung Transplant 15: 415-422, 1996.